Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386579966> ?p ?o ?g. }
- W4386579966 endingPage "10" @default.
- W4386579966 startingPage "1" @default.
- W4386579966 abstract "Background: The use of lipid-lowering drugs is still highly controversial in patients with amyotrophic lateral sclerosis (ALS). We performed a drug-target Mendelian randomization (MR) analysis to investigate the effect of targeted lipid-lowering drugs on the risk of ALS. Methods: First, we evaluated the causal relationship between HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase (HMGCR) inhibitors-taking trait and ALS using a bidirectional two-sample MR study. Second, we investigated the causal relationship between lipid-lowering drugs and ALS through a drug-target MR approach. The summary data for HMGCR inhibitors-taking traits were extracted from a genome-wide association study (GWAS) of medication use and associated disease in the UK Biobank. The summary data for low-density lipoprotein cholesterol and apolipoprotein B (apoB) were extracted from a meta-analysis of GWAS in individuals of European ancestry in the UKB. The GWAS summary data of ALS were obtained from the Project MinE. Results: Our bidirectional two-sample MR showed that genetically determined increased HMGCR inhibitors-taking trait was an independent risk factor for ALS (odds ratio [OR] = 1.090, 95% confidence interval [CI] = 1.035-1.150, p = 0.001). The results of drug-target MR showed that the increased expression of the HMGCR gene in blood with the higher risk of ALS (OR = 1.21, 95% CI = 1.01-1.46; p = 0.042) through SMR method and the apoB level mediated by the APOB gene increased the risk of ALS (OR = 1.15; 95% CI =1.05-1.25; p = 0.001) through inverse-variance weighted MR method. Conclusion: This present study provides genetic support for a positive causal effect of HMGCR inhibitors-taking trait and ALS. The reason for this may be due to the underlying disease condition behind the medication, rather than the medication itself. Our findings also suggested that HMGCR and apoB inhibitors may have potential protective effects on ALS." @default.
- W4386579966 created "2023-09-10" @default.
- W4386579966 creator A5037641781 @default.
- W4386579966 creator A5048869064 @default.
- W4386579966 creator A5050892306 @default.
- W4386579966 creator A5053257075 @default.
- W4386579966 creator A5058126365 @default.
- W4386579966 creator A5071866732 @default.
- W4386579966 creator A5081675173 @default.
- W4386579966 creator A5084558291 @default.
- W4386579966 creator A5085028455 @default.
- W4386579966 date "2023-09-09" @default.
- W4386579966 modified "2023-09-27" @default.
- W4386579966 title "Genetic variation in targets of lipid-lowering drugs and amyotrophic lateral sclerosis risk: a Mendelian randomization study" @default.
- W4386579966 cites W1974853369 @default.
- W4386579966 cites W1989797372 @default.
- W4386579966 cites W1989823864 @default.
- W4386579966 cites W2002354013 @default.
- W4386579966 cites W2061927518 @default.
- W4386579966 cites W2065012550 @default.
- W4386579966 cites W2065869202 @default.
- W4386579966 cites W2066321895 @default.
- W4386579966 cites W2101936044 @default.
- W4386579966 cites W2122716077 @default.
- W4386579966 cites W2125435699 @default.
- W4386579966 cites W2127277374 @default.
- W4386579966 cites W2131678573 @default.
- W4386579966 cites W2134796583 @default.
- W4386579966 cites W2154374203 @default.
- W4386579966 cites W2163396621 @default.
- W4386579966 cites W2171671253 @default.
- W4386579966 cites W2328393125 @default.
- W4386579966 cites W2461710273 @default.
- W4386579966 cites W2614566443 @default.
- W4386579966 cites W2749237115 @default.
- W4386579966 cites W2786977496 @default.
- W4386579966 cites W2803072880 @default.
- W4386579966 cites W2818417770 @default.
- W4386579966 cites W2903550412 @default.
- W4386579966 cites W2942053120 @default.
- W4386579966 cites W2952420414 @default.
- W4386579966 cites W3008362605 @default.
- W4386579966 cites W3012570809 @default.
- W4386579966 cites W3024511855 @default.
- W4386579966 cites W3034958546 @default.
- W4386579966 cites W3037039951 @default.
- W4386579966 cites W3093691938 @default.
- W4386579966 cites W3117515514 @default.
- W4386579966 cites W3135083450 @default.
- W4386579966 cites W3173906370 @default.
- W4386579966 cites W3185814702 @default.
- W4386579966 cites W3195817337 @default.
- W4386579966 cites W3201502209 @default.
- W4386579966 cites W3210570897 @default.
- W4386579966 cites W4220723775 @default.
- W4386579966 cites W4226286160 @default.
- W4386579966 cites W4255815262 @default.
- W4386579966 cites W4281551610 @default.
- W4386579966 cites W4289856294 @default.
- W4386579966 cites W4292648222 @default.
- W4386579966 cites W4295896242 @default.
- W4386579966 cites W4315621415 @default.
- W4386579966 cites W4327978528 @default.
- W4386579966 cites W4362458417 @default.
- W4386579966 doi "https://doi.org/10.1080/21678421.2023.2255622" @default.
- W4386579966 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37688479" @default.
- W4386579966 hasPublicationYear "2023" @default.
- W4386579966 type Work @default.
- W4386579966 citedByCount "0" @default.
- W4386579966 crossrefType "journal-article" @default.
- W4386579966 hasAuthorship W4386579966A5037641781 @default.
- W4386579966 hasAuthorship W4386579966A5048869064 @default.
- W4386579966 hasAuthorship W4386579966A5050892306 @default.
- W4386579966 hasAuthorship W4386579966A5053257075 @default.
- W4386579966 hasAuthorship W4386579966A5058126365 @default.
- W4386579966 hasAuthorship W4386579966A5071866732 @default.
- W4386579966 hasAuthorship W4386579966A5081675173 @default.
- W4386579966 hasAuthorship W4386579966A5084558291 @default.
- W4386579966 hasAuthorship W4386579966A5085028455 @default.
- W4386579966 hasBestOaLocation W43865799661 @default.
- W4386579966 hasConcept C104317684 @default.
- W4386579966 hasConcept C106208931 @default.
- W4386579966 hasConcept C126322002 @default.
- W4386579966 hasConcept C134018914 @default.
- W4386579966 hasConcept C135763542 @default.
- W4386579966 hasConcept C143998085 @default.
- W4386579966 hasConcept C153209595 @default.
- W4386579966 hasConcept C156957248 @default.
- W4386579966 hasConcept C2778163477 @default.
- W4386579966 hasConcept C2779134260 @default.
- W4386579966 hasConcept C2779901538 @default.
- W4386579966 hasConcept C2780596555 @default.
- W4386579966 hasConcept C2993967602 @default.
- W4386579966 hasConcept C54355233 @default.
- W4386579966 hasConcept C60644358 @default.
- W4386579966 hasConcept C62746215 @default.
- W4386579966 hasConcept C71924100 @default.
- W4386579966 hasConcept C86803240 @default.